Fractyl gets FDA approval for Revita DMR IDE study to treat diabetes
The study will evaluate Revita DMR, the first non-drug, non-surgical, disease-modifying therapy, to avoid need for insulin injections…
04 Jun 20
The study will evaluate Revita DMR, the first non-drug, non-surgical, disease-modifying therapy, to avoid need for insulin injections…
04 Jun 20
Marks 8th FDA clearance for BlueStar, the only reimbursable software as a medical device for diabetes that integrates…
27 May 20
Solara is an independent distributor of continuous glucose monitors (CGM), insulin pumps and other diabetic supplies
26 May 20
The Guardian Connect system is an individual CGM system that alarms patients of potential high or low sensor…
01 May 20
Free access to mySugr Pro to support both people with diabetes and healthcare professionals to improve remote diabetes…
21 Apr 20
The company has determined that one (1) isolated TRUE METRIX AIR Blood Glucose Meter was packaged into a…
16 Apr 20
60,000 patient image sets from 6 different diabetic eye screening programmes analyzed using EyeArt AI Eye Screening System
18 Mar 20
The first phase of the commercial launch of sugarBEAT began in the UK after the company received CE…
12 Mar 20
The collaboration is aimed at using Welldoc's digital health product BlueStar to deliver insights for individuals using Dexcom…
12 Mar 20
The U.S. District Court of New Jersey found the device patent claims asserted by Sanofi against Biocon and…